OncoXome, Inc.

OncoXome is developing a tumor-targeted exosome platform to safely deliver CRISPR therapies to solid tumors, starting with KRAS-mutant colorectal cancer.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Los Angeles, CA, USA
  • Currency USD
  • Founded January 2021
  • Employees 3
  • Incorporation Type C-corp
  • Website oncoxome.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free